Reading the Mastectomy Flap: The Decision That Is Still Open in Theatre

Direct-to-implant reconstruction is a single-stage operation that depends entirely on a judgement made in the middle of it. The mastectomy flap either will or will not tolerate a full-volume implant beneath it, and nobody knows which until the mastectomy is finished.

This article is about that judgement: what is being assessed, when, and — the part that matters most — what happens when the answer is no.

The decision cannot be made preoperatively

Patient selection narrows the field. Smoking status, BMI, diabetes, prior radiotherapy, breast size and ptosis, and the planned mastectomy incision all shift the probability that a flap will be suitable, and a good preoperative assessment declines some patients outright. What it cannot do is confirm suitability, because the thing being assessed does not exist until the specimen is out.

The flap is created by the oncological dissection. Its thickness, its blood supply and its handling are determined by where the oncological plane ran, and that plane is set by the disease, not by the reconstruction. A thin flap is often the correct oncological result. It is also, sometimes, an unsuitable reconstructive one, and both statements can be true of the same patient.

The general framing of the operation and its alternatives is covered in direct-to-implant reconstruction explained and in the guide to reconstruction options after mastectomy.

What is actually being read

Flap assessment is not one observation. It is several independent ones made at the same moment, and they can disagree.

Thickness is assessed across the whole flap rather than at its most convenient point. The relevant number is the thinnest area, not the average, because that is where the implant will show and where necrosis will start.

Colour and capillary refill report perfusion at the moment of looking. Both are affected by theatre temperature, by the patient’s blood pressure, and by how recently the flap was retracted, which is why an equivocal flap is worth re-examining after a few minutes rather than being judged on first appearance.

Dermal bleeding at the edge is the most direct evidence available of whether the flap has an arterial supply, and it is the observation least affected by ambient conditions.

Thermal imaging or indocyanine green angiography, where available, quantifies what the eye is estimating. It is an adjunct, not an arbiter: a perfusion map does not know how much tension the implant is about to add.

The last point is the one most often skipped. Every observation above is made on an unloaded flap. A full-volume implant adds tension, and tension reduces perfusion. A flap that is marginal at rest is not marginal under load; it is worse than it looks.

The abort decision

The reason to formalise this is that the decision is made under pressure — late in a long operation, with a consented plan, a patient who wants one operation, and a theatre list running behind. Those are precisely the conditions in which an equivocal flap gets called acceptable.

The structure that helps is to treat the criteria as conjunctive rather than as a score. All of them have to be satisfied. Any one in genuine doubt sends the operation down the alternative path, and “genuine doubt” is not a failure of nerve — it is the assessment working.

The alternative path is not a failure either. Placing a tissue expander converts a single-stage plan into a two-stage one, which is a well-established reconstruction in its own right, described in two-stage tissue expander reconstruction. A partially filled expander reduces tension on a compromised flap and allows expansion to be deferred until the flap has demonstrated it will survive. Delayed reconstruction, discussed in immediate versus delayed reconstruction, remains available and produces good results.

What is not available is a second chance at this decision. Once a full-volume implant is in and the skin is closed, the mechanism that would allow the flap to recover — reduced tension — has been removed. The consequences of getting it wrong are flap necrosis, exposure, infection, explantation, and a reconstruction that ends up taking longer than the two-stage route it was chosen to avoid.

Consenting for a decision rather than an operation

The practical implication is that a patient being consented for direct-to-implant reconstruction should be consented for both outcomes. This is straightforward to explain and patients generally accept it readily: the plan is a single-stage reconstruction, the decision is made during surgery once the tissue can be seen, and if the tissue is not suitable an expander will be placed instead.

A patient who has heard that sentence beforehand experiences an expander as the plan working correctly. A patient who has not experiences it as something having gone wrong, and that impression is difficult to undo afterwards.

Where the matrix fits

An acellular matrix or mesh changes what the reconstruction can do with a suitable flap — it supports the implant, defines the lower pole, and in prepectoral reconstruction provides the coverage that the muscle used to provide. It does not change the flap. A matrix cannot perfuse thin skin, and a reconstruction that relies on one to compensate for a marginal flap has substituted a device for a judgement.

The evidence on what matrices do and do not achieve is reviewed in the clinical evidence for biological matrices and the selection framework in choosing a biological matrix. How the matrix is actually used in a prepectoral single-stage reconstruction is set out in the prepectoral direct-to-implant technique.

Nipple-sparing mastectomy sharpens all of this

Nipple-sparing mastectomy adds a further perfusion-dependent structure to the same flap, with its own blood supply arriving through the tissue just assessed. The nipple-areola complex can be lost while the rest of the flap survives, and the assessment therefore has to be made separately for it. See nipple-sparing mastectomy and reconstruction.

The short version

Direct-to-implant is a single-stage operation with a two-stage consent. The flap is read cold, under load, in several independent ways, and any one of them in doubt is enough. The expander is not the failure — ignoring the reading is.

This article is educational material for clinicians and describes the structure of an intraoperative judgement, not a threshold or a protocol. No flap thickness or perfusion cut-off is given, because those are assessments of a particular tissue in a particular patient.